Arturo Casadevall is an Infectious Disease provider in Bronx, New York. Dr. Casadevall is rated as an Elite provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Cryptococcosis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Anthrax Infection.

Sally Wenzel is a Pulmonary Medicine provider in Pittsburgh, Pennsylvania. Dr. Wenzel is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Asthma, Eosinophilic Asthma, Eosinophilic Pneumonia, Chronic Eosinophilic Pneumonia, and Endoscopy. Dr. Wenzel is currently accepting new patients.

Katarina Dakay is a Neurologist in Park Ridge, Illinois. Dr. Dakay is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Subarachnoid Hemorrhage, Stroke, Vasoconstriction, Thrombectomy, and Transmyocardial Revascularization.

Viviana Martinez-Bianchi is a primary care provider, practicing in Family Medicine in Durham, North Carolina. Dr. Martinez-Bianchi is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Post Polio Syndrome, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Urinary Incontinence. Dr. Martinez-Bianchi is currently accepting new patients.

Sneha Mantri is a Neurologist in Durham, North Carolina. Dr. Mantri is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Parkinson's Disease, Movement Disorders, Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy, and Deep Brain Stimulation. Dr. Mantri is currently accepting new patients.

Brian Chicoine is a primary care provider, practicing in Family Medicine in Park Ridge, Illinois. Dr. Chicoine is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Down Syndrome, Alzheimer's Disease, Hypothyroidism, and Cellulitis.

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Lung Transplant, and Embolectomy.

Nadine Rouphael is an Infectious Disease provider in Atlanta, Georgia. Dr. Rouphael has been practicing medicine for over 25 years and is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are COVID-19, Flu, Severe Acute Respiratory Syndrome (SARS), and Avian Influenza.

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009. Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master’s Degree in Clinical Epidemiology. Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research. Dr. Gong is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Severe Acute Respiratory Syndrome (SARS), and Cerebral Hypoxia.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Liise-anne Pirofski is a physician-scientist. Her research programs focus on host-microbe interaction and antibody immunity to infectious diseases. Dr. Pirofski is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Cryptococcosis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Meningitis.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Acute Respiratory Distress Syndrome (ARDS), and Cerebral Hypoxia.

Jason Goldman is an Infectious Disease provider in Seattle, Washington. Dr. Goldman is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Long Haul COVID, and Kaposi Sarcoma. Dr. Goldman is currently accepting new patients.

Ithan Peltan is an Intensive Care Medicine provider in Salt Lake City, Utah. Dr. Peltan has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Acute Respiratory Distress Syndrome (ARDS), and Cerebral Hypoxia.

Syed Shirazee is a Cardiologist and a Pulmonary Medicine provider in Atoka,, Tennessee. Dr. Shirazee is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Gastrostomy, and Endoscopy.

Mark Mulligan is an Infectious Disease provider in Atlanta, Georgia. Dr. Mulligan is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are COVID-19, Yellow Fever, Zika Virus Disease, and Severe Acute Respiratory Syndrome (SARS).

Steven Galetta is a Neurologist in New York, New York. Dr. Galetta is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Optic Neuritis, Multiple Sclerosis (MS), Brown Syndrome, Concussion, and Thrombectomy.

Maricar Malinis is an Infectious Disease provider in Nashville, Tennessee. Dr. Malinis is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Tissue Biopsy. Dr. Malinis is currently accepting new patients.